Clinical Scorecard: Lung Adenocarcinoma-Induced Leptomeningeal Metastasis Complicated by Lemierre Syndrome: A Case Study and Literature Review
At a Glance
Category
Detail
Condition
Key Mechanisms
Oropharyngeal infection leading to internal jugular vein thrombosis and metastatic spread of lung adenocarcinoma; clarify the role of Fusobacterium necrophorum.
Target Population
Care Setting
Key Highlights
Lemierre syndrome is characterized by oropharyngeal infection, jugular vein thrombosis, and anaerobic pathogens.
Lung adenocarcinoma has a high metastatic potential, with 30%-40% of patients developing leptomeningeal metastasis.
Co-occurrence of Lemierre syndrome and lung adenocarcinoma with leptomeningeal metastasis is extremely rare.
Guideline-Based Recommendations
Diagnosis
Management
Initiate anticoagulation therapy (e.g., rivaroxaban) with specific dosage and duration, and antimicrobial therapy with anaerobic coverage.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Anticoagulation and targeted antimicrobial therapy are critical for managing Lemierre syndrome; include monitoring for side effects.
Clinical Best Practices
Maintain high clinical vigilance for Lemierre syndrome in patients with recent oropharyngeal infections; consider interdisciplinary collaboration.
When advanced technology and data from patients’ individual cells join forces, they can enormously expand what we know about cancer and how to treat it.
Researchers from Roswell Park Comprehensive Cancer Center will report their latest findings to colleagues from around the world at the 2025 annual meeting of the American Association for Cancer Research (AACR) in Chicago, Illinois, April 25-30.
